Today's Top Patent Stories

1. Generic Semaglutide patent expiry opens over Rs 50000 Cr opportunity for drugmakers: Report

The patent expiry of semaglutide drugs is set to unlock a significant revenue opportunity exceeding Rs 50 billion for generic drug manufacturers ...

2. Ferrari patents predictive active aero for road cars - SpeedMe.ru

Ferrari keeps bringing racing logic to the street, and this time it's tackling active aerodynamics. A patent that reporters at SPEEDME.

3. Ferrari's predictive active aerodynamics patent for road cars - SpeedMe.ru

... patents-predictive-active-aero-for-road-cars. Ferrari patents predictive active aero for road cars. Ferrari's predictive active aerodynamics patent ...

4. You Can't Park Patent Rights in the E-Ricksha Registration Lane | Intellepedia

Intellectual Property, Case Reviews, Patents. Tags. Calcutta High Court, e-rickshaw regulation, motor vehicles act, Patent Law. Post navigation.

5. Novo Nordisk, Eli Lilly Slash Prices in China

The reason patent periods for drugs vary by country is because patents follow the principle of territoriality. If local pharmaceutical companies ...

6. Patent Filings Document Technical Work by Navneeth Kankani Across Storage and ...

Publicly available patent records show that Navneeth Kankani has been named as an inventor on multiple patents over the past decade.

7. Boehringer Ingelheim v. Lotus Pharmaceutical: Sufficient Causation between Generic ... - Lexology

Boehringer Ingelheim International GmbH (“Boehringer”) owns three Taiwanese patents--Nos. I268922, I285635, and I418351--relating to nintedanib, a ...

8. Universal patents new safety measures after tourist died on ride - MSN

The family of a man who died on a ride said 'multiple warning signs' were missed — now Universal Studios seeks new patents to improve safety ...

9. China strengthens intellectual property protection in solar industry - PV Magazine

... patents for developing technologies ... Chinese enterprises are being encouraged to accelerate technological advancements and reserve basic patents for ...